12:00 AM
 | 
Apr 27, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Armala pazopanib regulatory update

GlaxoSmithKline said that last month it submitted an MAA to EMEA for Armala pazopanib to treat advanced and/or metastatic renal...

Read the full 76 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >